Pacira BioSciences Inc.

News & Events

Press Releases

In The Media

1. Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient's Journey to Pain Relief and Innovation in Care at BIO 2025

   GlobeNewswire JUN 18, 2025 8:00 AM EDT
   - Produced for Pacira by BBC StoryWorks Commercial Productions, The Next Frontier: Mark & Lea...
   READ ARTICLE

2. PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

   GlobeNewswire JUN 17, 2025 9:00 PM EDT
   NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recogni...
   READ ARTICLE

3. Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee

   GlobeNewswire JUN 11, 2025 8:00 AM EDT
   -- PCRX-201 demonstrated sustained clinical efficacy with improvements in pain, stiffness, and fu...
   READ ARTICLE

4. Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   GlobeNewswire JUN 5, 2025 8:00 AM EDT
   BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the ...
   READ ARTICLE

5. Grabar Law Office Investigates Claims on Behalf of Shareholders of Pacira Biosciences Inc. (PCRX)

   Newsfile MAY 27, 2025 3:47 PM EDT
   Philadelphia, Pennsylvania--(Newsfile Corp. - May 27, 2025) - If you have held Pacira BioSciences...
   READ ARTICLE

6. Grabar Law Office Investigates Claims on Behalf of Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); NAPCO Securities Technologies, Inc. (NASDAQ: NSSC); Pacira Biosciences, Inc. (NASDAQ: PCRX); and Treace Medical Concepts, Inc. (NASDAQ: TMCI)

   GlobeNewswire MAY 26, 2025 9:54 PM EDT
   PHILADELPHIA, May 26, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): ...
   READ ARTICLE

7. Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee

   GlobeNewswire MAY 15, 2025 8:00 AM EDT
   -- Early clinical data indicates that Pre-existing and treatment-induced anti-Ad5 neutralizing an...
   READ ARTICLE

8. Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

   GlobeNewswire MAY 14, 2025 8:00 AM EDT
   BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the i...
   READ ARTICLE

9. Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation

   PR Newswire MAY 13, 2025 10:35 AM EDT
   Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Share...
   READ ARTICLE

10. Pacira BioSciences Reports First Quarter 2025 Financial Results

    GlobeNewswire MAY 8, 2025 4:00 PM EDT
    -- Conference call today at 4:30 p.m. ET -- BRISBANE, Calif., May 08, 2025 (GLOBE NEWSWIRE)...
    READ ARTICLE